{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:27:59Z","timestamp":1786591679790,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01158-4","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:15:39Z","timestamp":1780683339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In-vitro pharmacological and cytotoxic evaluation of genipin-crosslinked human serum albumin nanoparticles loaded with methyltestosterone in MCF-7 breast cancer cells"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4761-0167","authenticated-orcid":false,"given":"Elena","family":"Ganji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0717-876X","authenticated-orcid":false,"given":"Maryam","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8870-594X","authenticated-orcid":false,"given":"Aref","family":"Arminfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4729-648X","authenticated-orcid":false,"given":"Midiya","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1158_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","volume":"15","author":"S Hossen","year":"2019","unstructured":"Hossen S, Hossain MK, Basher M, Mia M, Rahman M, Uddin MJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. J Adv Res. 2019;15:1\u201318.","journal-title":"J Adv Res"},{"issue":"10","key":"1158_CR2","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djq088","volume":"102","author":"E Amir","year":"2010","unstructured":"Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. JNCI: J Natl Cancer Inst. 2010;102(10):680\u201391.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"2","key":"1158_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbcan.2019.04.006","volume":"1871","author":"PY Liyanage","year":"2019","unstructured":"Liyanage PY, Hettiarachchi SD, Zhou Y, Ouhtit A, Seven ES, Oztan CY, et al. Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochim et Biophys Acta (BBA)-Reviews Cancer. 2019;1871(2):419\u201333.","journal-title":"Biochim et Biophys Acta (BBA)-Reviews Cancer"},{"issue":"3","key":"1158_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","volume":"55","author":"J Panyam","year":"2003","unstructured":"Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329\u201347.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1158_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/21691401.2013.768627","volume":"42","author":"G Ak","year":"2014","unstructured":"Ak G, Y\u026almaz H, Sanl\u026aer SH. Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies. Artif cells Nanomed Biotechnol. 2014;42(1):18\u201326.","journal-title":"Artif cells Nanomed Biotechnol"},{"key":"1158_CR6","first-page":"51","volume":"1","author":"G Singhvi","year":"2020","unstructured":"Singhvi G, Rapalli VK, Nagpal S, Dubey SK, Saha RN. Nanocarriers as potential targeted drug delivery for cancer therapy. Nanosci Med. 2020;1:51\u201388.","journal-title":"Nanosci Med"},{"key":"1158_CR7","doi-asserted-by":"crossref","unstructured":"Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein nanoparticles as drug delivery carriers for cancer therapy. BioMed Res Int. 2014;2014.","DOI":"10.1155\/2014\/180549"},{"issue":"1","key":"1158_CR8","first-page":"31","volume":"5","author":"Z Rajabi","year":"2021","unstructured":"Rajabi Z, Bagheri F, Shojaosadati SA. The effect of 5-fluorouracil loaded albumin magnetic nanoparticles on viability and cell cycle of human breast cancer MCF-7 cell line. J Appl Res Chemical-Polymer Eng. 2021;5(1):31\u201341.","journal-title":"J Appl Res Chemical-Polymer Eng"},{"key":"1158_CR9","doi-asserted-by":"crossref","unstructured":"Kadri H, Alshatfa M, Alsalloum FZ, Elhissi A, Daou A, Khoder M. Albumin nanoparticles in cancer therapeutics: clinical status, challenges, and future directions. Pharmaceutics. 2025;17(10).","DOI":"10.3390\/pharmaceutics17101290"},{"issue":"1\u20132","key":"1158_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2010.12.023","volume":"406","author":"K Ulbrich","year":"2011","unstructured":"Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, et al. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int J Pharm. 2011;406(1\u20132):128\u201334.","journal-title":"Int J Pharm"},{"key":"1158_CR11","unstructured":"Kouchakzadeh H, Hoseini MS, Shojaosadati S. Simultaneous loading of 5-florouracil and SPIONs in HSA nanoparticles: Optimization of preparation, characterization and in vitro drug release study. 2016."},{"key":"1158_CR12","doi-asserted-by":"crossref","unstructured":"Cho H, Jeon SI, Ahn CH, Shim MK, Kim K. Emerging albumin-binding anticancer drugs for tumor-targeted drug delivery: current understandings and clinical translation. Pharmaceutics. 2022;14(4).","DOI":"10.3390\/pharmaceutics14040728"},{"key":"1158_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ijbiomac.2017.06.083","volume":"104","author":"N Shahgholian","year":"2017","unstructured":"Shahgholian N, Rajabzadeh G, Malaekeh-Nikouei B. Preparation and evaluation of BSA-based hydrosol nanoparticles cross-linked with genipin for oral administration of poorly water-soluble curcumin. Int J Biol Macromol. 2017;104:788\u201398.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"1158_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1515\/ijfe-2014-0314","volume":"11","author":"M Luo","year":"2015","unstructured":"Luo M, Peng H, Deng Z, Yin Z, Zhao Q, Xiong H. Preparation and characterization of genipin-crosslinked chitosan microspheres for the sustained release of salidroside. Int J Food Eng. 2015;11(3):323\u201333.","journal-title":"Int J Food Eng"},{"issue":"Pt 6","key":"1158_CR15","doi-asserted-by":"publisher","first-page":"137478","DOI":"10.1016\/j.ijbiomac.2024.137478","volume":"282","author":"D Xu","year":"2024","unstructured":"Xu D, Hui YY, Zhang W, Zhao MN, Gao K, Tao XR, et al. Genipin-crosslinked hydrogels for food and biomedical applications: A scientometric review. Int J Biol Macromol. 2024;282(Pt 6):137478.","journal-title":"Int J Biol Macromol"},{"key":"1158_CR16","doi-asserted-by":"publisher","first-page":"108758","DOI":"10.1016\/j.steroids.2020.108758","volume":"165","author":"S Alaedini","year":"2021","unstructured":"Alaedini S, Amirahmadi M, Kobarfard F, Rastegar H, Nasirahmadi S, Shoeibi S. Survey of protein-based sport supplements for illegally added anabolic steroids methyltestosterone and 4-androstenedione by UPLC-MS\/MS. Steroids. 2021;165:108758.","journal-title":"Steroids"},{"key":"1158_CR17","first-page":"12","volume":"6","author":"DL Savaris","year":"2019","unstructured":"Savaris DL, Alberton MB, de Matos R, Fernanda M, Zalazar DJ, Lindino CA. Development of Spectrophotometric Method for the Determination of 17\u03b1-Methyltestosterone. Br J Anal Chem. 2019;6:12\u20139.","journal-title":"Br J Anal Chem"},{"key":"1158_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.beproc.2013.06.004","volume":"99","author":"K Ramos-Pratts","year":"2013","unstructured":"Ramos-Pratts K, Rosa-Gonz\u00e1lez D, P\u00e9rez-Acevedo NL, Cintr\u00f3n-L\u00f3pez D, Barreto-Estrada JL. Sex-specific effect of the anabolic steroid, 17\u03b1-methyltestosterone, on inhibitory avoidance learning in periadolescent rats. Behav Process. 2013;99:73\u201380.","journal-title":"Behav Process"},{"issue":"1\u20132","key":"1158_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00170-021-08235-4","volume":"119","author":"X Wang","year":"2022","unstructured":"Wang X, Li C, Zhang Y, Said Z, Debnath S, Sharma S, et al. Influence of texture shape and arrangement on nanofluid minimum quantity lubrication turning. Int J Adv Manuf Technol. 2022;119(1\u20132):631\u201346.","journal-title":"Int J Adv Manuf Technol"},{"issue":"5","key":"1158_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12918-017-0464-7","volume":"11","author":"J Sun","year":"2017","unstructured":"Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H. A systematic analysis of FDA-approved anticancer drugs. BMC Syst Biol. 2017;11(5):1\u201317.","journal-title":"BMC Syst Biol"},{"issue":"1","key":"1158_CR21","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/bcr3599","volume":"16","author":"DR Cochrane","year":"2014","unstructured":"Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D\u2019Amato NC, et al. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res. 2014;16(1):R7.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1158_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41591-020-01168-7","volume":"27","author":"TE Hickey","year":"2021","unstructured":"Hickey TE, Selth LA, Chia KM, Laven-Law G, Milioli HH, Roden D, et al. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nat Med. 2021;27(2):310\u201320.","journal-title":"Nat Med"},{"key":"1158_CR23","doi-asserted-by":"publisher","first-page":"131417","DOI":"10.1016\/j.snb.2022.131417","volume":"357","author":"J Zhang","year":"2022","unstructured":"Zhang J, Pei W, Xu Q, Jiang H, Chen J. Desolvation-induced formation of recombinant camel serum albumin-based nanocomposite for glutathione colorimetric determination. Sens Actuators B. 2022;357:131417.","journal-title":"Sens Actuators B"},{"issue":"3","key":"1158_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jconrel.2008.03.017","volume":"128","author":"A Agarwal","year":"2008","unstructured":"Agarwal A, Lvov Y, Sawant R, Torchilin V. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. J Controlled Release. 2008;128(3):255\u201360.","journal-title":"J Controlled Release"},{"key":"1158_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.carbpol.2016.09.087","volume":"157","author":"C Saikia","year":"2017","unstructured":"Saikia C, Das MK, Ramteke A, Maji TK. Evaluation of folic acid tagged aminated starch\/ZnO coated iron oxide nanoparticles as targeted curcumin delivery system. Carbohydr Polym. 2017;157:391\u20139.","journal-title":"Carbohydr Polym"},{"issue":"5","key":"1158_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.carres.2009.01.012","volume":"344","author":"K Ghosh","year":"2009","unstructured":"Ghosh K, Chandra K, Ojha AK, Sarkar S, Islam SS. Structural identification and cytotoxic activity of a polysaccharide from the fruits of Lagenaria siceraria (Lau). Carbohydr Res. 2009;344(5):693\u20138.","journal-title":"Carbohydr Res"},{"key":"1158_CR27","doi-asserted-by":"crossref","unstructured":"Parhamifar L, Andersen H, Moghimi SM. Lactate dehydrogenase assay for assessment of polycation cytotoxicity. Nanatechnol Nucleic Acid Delivery: Methods Protocols. 2013:13\u201322.","DOI":"10.1007\/978-1-62703-140-0_2"},{"issue":"4","key":"1158_CR28","first-page":"714","volume":"9","author":"M Mirzaei","year":"2021","unstructured":"Mirzaei M, Tebyanian H, Izadpanah S, Moradi RS, Panahi MRS, Moghaddam MM, et al. Investigation of Paraxon-induced PC12 cells viability, cytotoxicity, and apoptosis in the presence of recombinant butyrylcholinesterase (BCHE). J Environ Treat Techniques. 2021;9(4):714\u20139.","journal-title":"J Environ Treat Techniques"},{"issue":"6","key":"1158_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. Cancer J Clin. 2019;69(6):438\u201351.","journal-title":"Cancer J Clin"},{"issue":"3","key":"1158_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288\u2013300.","journal-title":"JAMA"},{"issue":"5","key":"1158_CR31","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1021\/acs.jpcc.9b11371","volume":"124","author":"D Biriukov","year":"2020","unstructured":"Biriukov D, Fibich P, P\u0159edota M. Zeta potential determination from molecular simulations. J Phys Chem C. 2020;124(5):3159\u201370.","journal-title":"J Phys Chem C"},{"issue":"5","key":"1158_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/02652048.2018.1524524","volume":"35","author":"B Khatun","year":"2018","unstructured":"Khatun B, Banik N, Hussain A, Ramteke A, Maji T. Genipin crosslinked curcumin loaded chitosan\/montmorillonite K-10 (MMT) nanoparticles for controlled drug delivery applications. J Microencapsul. 2018;35(5):439\u201353.","journal-title":"J Microencapsul"},{"key":"1158_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00280-019-03832-3","volume":"83","author":"K Kimura","year":"2019","unstructured":"Kimura K, Yamasaki K, Nishi K, Taguchi K, Otagiri M. Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique. Cancer Chemother Pharmacol. 2019;83:1113\u201320.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1158_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.supflu.2013.02.029","volume":"77","author":"PSC Sacchetin","year":"2013","unstructured":"Sacchetin PSC, Morales AR, Moraes \u00c2M, e Rosa PdTV. Formation of PLA particles incorporating 17\u03b1-methyltestosterone by supercritical fluid technology. J Supercrit Fluids. 2013;77:52\u201362.","journal-title":"J Supercrit Fluids"},{"key":"1158_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.msec.2015.09.071","volume":"58","author":"PSC Sacchetin","year":"2016","unstructured":"Sacchetin PSC, Setti RF, e Rosa PdTV, Moraes \u00c2M. Properties of PLA\/PCL particles as vehicles for oral delivery of the androgen hormone 17\u03b1-methyltestosterone. Mater Sci Engineering: C. 2016;58:870\u201381.","journal-title":"Mater Sci Engineering: C"},{"issue":"3","key":"1158_CR36","doi-asserted-by":"publisher","first-page":"035103","DOI":"10.1088\/0957-4484\/24\/3\/035103","volume":"24","author":"B Subia","year":"2012","unstructured":"Subia B, Kundu S. Drug loading and release on tumor cells using silk fibroin\u2013albumin nanoparticles as carriers. Nanotechnology. 2012;24(3):035103.","journal-title":"Nanotechnology"},{"issue":"1","key":"1158_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/07388551.2017.1312267","volume":"38","author":"H Malekzad","year":"2018","unstructured":"Malekzad H, Mirshekari H, Sahandi Zangabad P, Moosavi Basri S, Baniasadi F, Sharifi Aghdam M, et al. Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems. Crit Rev Biotechnol. 2018;38(1):47\u201367.","journal-title":"Crit Rev Biotechnol"},{"issue":"12","key":"1158_CR38","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/cancers13123011","volume":"13","author":"R Prajapati","year":"2021","unstructured":"Prajapati R, Garcia-Garrido E, Somoza \u00c1. Albumin-based nanoparticles for the delivery of doxorubicin in breast cancer. Cancers. 2021;13(12):3011.","journal-title":"Cancers"},{"issue":"4","key":"1158_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.addr.2003.10.030","volume":"56","author":"C Bies","year":"2004","unstructured":"Bies C, Lehr C-M, Woodley JF. Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev. 2004;56(4):425\u201335.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1158_CR40","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/1055-9965.EPI-20-1193","volume":"30","author":"SC Houghton","year":"2021","unstructured":"Houghton SC, Hankinson SE. Cancer Progress and Priorities: Breast Cancer. Cancer Epidemiology. Biomarkers Prev. 2021;30(5):822\u201344.","journal-title":"Biomarkers Prev"},{"key":"1158_CR41","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.2147\/IJN.S467876","volume":"19","author":"N Qu","year":"2024","unstructured":"Qu N, Song K, Ji Y, Liu M, Chen L, Lee RJ, et al. Albumin Nanoparticle-Based Drug Delivery Systems. Int J Nanomed. 2024;19:6945\u201380.","journal-title":"Int J Nanomed"},{"key":"1158_CR42","doi-asserted-by":"publisher","first-page":"1409163","DOI":"10.3389\/fphar.2024.1409163","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li Y, Shen W, Li M, Wang W, Jin X. Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects. Front Pharmacol. 2024;15:1409163.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1158_CR43","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","volume":"18","author":"A Spada","year":"2021","unstructured":"Spada A, Emami J, Tuszynski JA, Lavasanifar A. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Mol Pharm. 2021;18(5):1862\u201394.","journal-title":"Mol Pharm"},{"issue":"16","key":"1158_CR44","doi-asserted-by":"publisher","first-page":"14251","DOI":"10.1007\/s00289-024-05406-7","volume":"81","author":"MI Wahba","year":"2024","unstructured":"Wahba MI. A comprehensive review on genipin: an efficient natural cross-linker for biopolymers. Polym Bull. 2024;81(16):14251\u2013305.","journal-title":"Polym Bull"},{"key":"1158_CR45","doi-asserted-by":"publisher","first-page":"127241","DOI":"10.1016\/j.foodchem.2020.127241","volume":"330","author":"R Luo","year":"2020","unstructured":"Luo R, Lin M, Zhang C, Shi J, Zhang S, Chen Q, et al. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chem. 2020;330:127241.","journal-title":"Food Chem"},{"key":"1158_CR46","doi-asserted-by":"crossref","unstructured":"Chilom CG, Iftimie S, Balan AE, Oprea D, Enculescu M, Enache TA. Human serum albumin-based nanoparticles for targeted intracellular drug delivery. Int J Mol Sci. 2025;26(17).","DOI":"10.3390\/ijms26178297"},{"key":"1158_CR47","doi-asserted-by":"publisher","first-page":"123570","DOI":"10.1016\/j.ijpharm.2023.123570","volume":"648","author":"R Ghadi","year":"2023","unstructured":"Ghadi R, Pandey PK, Gabhale A, Wadikar A, Dharshini M, Kuche K, et al. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer. Int J Pharm. 2023;648:123570.","journal-title":"Int J Pharm"},{"key":"1158_CR48","doi-asserted-by":"publisher","first-page":"746646","DOI":"10.3389\/fchem.2021.746646","volume":"9","author":"X Shen","year":"2021","unstructured":"Shen X, Liu X, Li T, Chen Y, Chen Y, Wang P, et al. Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy. Front Chem. 2021;9:746646.","journal-title":"Front Chem"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01158-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:47:40Z","timestamp":1786589260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01158-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01158-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study did not involve human participants, human data, human tissue, or animal experiments; therefore, ethics approval and consent to participate were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"108"}}